Gotestam SkorpenCHoeltzenbeinMTincaniAet al.The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis2016; 75: 795–810.
2.
PilarskiLMYacyshynBRLazarovitsAI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation1994; 57: 133–144.
3.
WilesKChandiramaniMJiwaniSNelson-PiercyC. A retrospective study of anaemia in neonates exposed to thiopurines in utero. Gut2016; 65: 886–887.
4.
JharapBde BoerNKStokkersPet al.Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut2014; 63: 451–457.
5.
GardinerSJGearryRBRobertsRLZhangMBarclayMLBeggEJ. Comment: Breast-feeding during maternal use of azathioprine. Ann Pharmacother2007; 41: 719–720. author reply 720.
